A decided public DOHA case, shown for research, not advice or a prediction.
ISCR Case No. 25-01320
GrantedDecided Oct 1, 2026 · Administrative Judge Candace Le'i Garcia · Hearing
Case headnote
Summary
The applicant, a 33-year-old male with a history of illegal drug use, sought a security clearance under Guideline H (Drug Involvement and Substance Misuse). He admitted to using marijuana daily from January 2018 to April 2024, as well as hallucinogenic mushrooms and LSD in 2019. The judge granted the clearance, finding that the applicant had established a sufficient period of abstinence and demonstrated a commitment to a drug-free lifestyle.
Why the applicant prevailed
- The applicant ceased all illegal drug use in April 2024, prior to starting his current position.
- He demonstrated a sufficient period of abstinence from illegal drugs, with nearly two years since last use.
- The applicant provided evidence of positive changes in his life, including support from his spouse and a signed statement of intent to abstain from drug use.
Conditions referenced
Disqualifying
- AG ¶ 25(a) Substance misuseraised
- AG ¶ 25(c) Illegal possession of a controlled substanceraised
- AG ¶ 25(f) Illegal drug use while holding a sensitive positionraised
Mitigating
- AG ¶ 26(a) Behavior unlikely to recurapplied
- AG ¶ 26(b) Acknowledgment of drug involvement and actions taken to overcome itapplied
- AG ¶ 26(b)(1) Disassociation from drug-using associatesapplied
- AG ¶ 26(b)(2) Avoiding environments where drugs are usedapplied
- AG ¶ 26(b)(3) Signed statement of intent to abstain from drug useapplied
Key rule quoted
“The illegal use of controlled substances... can raise questions about an individual’s reliability and trustworthiness.”
Procedural posture
- SOR issued
- 01/23/2026
- Answer filed
- 02/02/2026
- Hearing held
- 05/07/2026 via video teleconference
- Decision date
- 10/01/2026
Cite for
- Establishing a Sufficient Period of Abstinence From Illegal Drug Use
- Importance of Support Systems in Mitigating Drug Involvement
- The Relevance of Signed Statements of Intent Regarding Drug Use
Editorial summary generated for research. Not legal advice; not a prediction. Verify against the full decision before relying on any quoted language.
From the decision
Facts this decision states, each with the sentence it comes from. Descriptive of the record, not an assessment.
- Applicant Age
- 33
- Years in Industry
- 2
- Prior Clearance
- held
- Bankruptcy
- none
Allegations under Guideline H
Reading the 7 per allegation rows needs a free account.
7 rows in this decision.
It opens the per allegation record on every guideline: the amounts, the findings, and the sentence behind each row.
Descriptive standardized rendering of a decided public case. The verbatim source decision is below.
Full decision
Open original PDFThe complete official text, footnotes and signatures included, is in the original PDF.
Decision text, by section
Appearances
mation is granted. Statement of the Case On January 23, 2026, the Defense C
Decision
ounterintelligence and Security Agency (DCSA) issued a Statement of Reasons (SOR) to Applicant detailing security concerns under Guideline H. Applicant r
Statement of Case
esponded to the SOR on February 2, 2026 (Answer) and requested a hearing before an administrative judge. The case was assigned to me on April 8, 2026. The Defense Office of Hearings and Appeals (DOHA) issued a notice on April 13, 2026, scheduling the matter for a video teleconference (VTC) hearing on May 7, 2026. I convened the hearing as scheduled. At the hearing, I admitted in evidence without objection Government Exhibits (GE) 1-2. Applicant testified, did not call any witnesses, and submitted documentation that I marked and admitted in evidence without objection as Applicant Exhibits (AE) A-B. Neither party requested to keep the record open for additional documentation and the record closed. DOHA received the hearing transcript (Tr.) on May 21, 2026.
Findings of Fact
Applicant admitted all the SOR allegations in his Answer. He disclosed his illegal drug use on his December 2024 security clearance application (SCA), during his May 2025 background interview, in his January 2026 response to interrogatories, and during his testimony at the hearing. (GE 1-2; Tr. 14-15, 30-33) Applicant is 33 years old, married, and he does not have any children. He has lived in State 1 since October 2024. He previously lived in State 1 from January 2015 to August 2015 and June 2016 to August 2020, and he previously lived in State 2 from August 2020 to October 2024. (Answer; GE 1-2; Tr. 6, 20, 33-34) Applicant graduated from high school in June 2011. He attended college from August 2011 to June 2016 and obtained a bachelor’s degree. While in college, he interned for a defense contracting company, Company A, located in State 1, from January 2015 to August 2015. During this internship, he was granted a security clearance in April 2015, and he had access to classified information as of June 2015. He returned to work full time for Company A, with access to classified information, from June 2016 to August 2020. (GE 1-2; Tr. 5-9, 20-21, 25, 33-34) When asked by Department Counsel his reason for leaving Company A in 2020, Applicant stated: So, at the time, I -- I felt a -- an -- a sort of, kind of speaking a bit with a bit of vulnerability here. At the time, I -- I was very confused, frustrated with who I was in the world, my place in the world, how to navigate this life as an adult and day-to-day life. And one of the things that I came to as a conclusion was to change my life dynamic entirely. You could call it a -- a soul searching journey. You could call it just a change of -- of environment, but I felt at the time to leave [State 1] and to leave the [Department of Defense] behind in pursuit of a changed lifestyle. And that's what led me to ultimately distance myself from [Company A] and -- and move from [State 1]. (Tr. 25) Applicant then worked for two different defense contracting companies, both located in State 2, from September 2020 to October 2020, and briefly in February 2023, respectively. He had two periods of unemployment, from October 2020 to April 2021 and from April 2024 to August 2024. He did not have a security clearance during these periods of employment in State 2 or during his periods of unemployment. Since November 2024, he has worked for Company A as a digital engineer. In connection with his employment, he completed a SCA in December 2024. (GE 1-2; Tr. 5-9, 20-21, 25, 33-34) Applicant used marijuana from January 2018 to April 2024. He used it daily, either by smoking it or by taking an edible. He used it recreationally, out of curiosity, and as a sleep aid, and primarily at his residence. Initially, he used it with former college associates and friends while living in State 1. When he moved to State 2, he used it alone. He also 2
purchased marijuana for his personal use from January 2018 to March 2024. He stated in his SCA, “I acquired an interest in THC for many years starting in [State 1,] which I went out of my way to obtain by word of mouth. . . . As an aside, THC was legally obtainable for me while I lived in [State 2].” (GE 1) He spent $200 every other month when he purchased marijuana in State 1, and he spent $200 every three weeks when he purchased marijuana from dispensaries in State 2, where marijuana use and purchase is legal under State B law. He last purchased marijuana in March 2024, and he last used it in April 2024, while still living in State 2 and before he started working in his current position with Company A in November 2024. (SOR ¶¶ 1.a-1.b; GE 1-2; Tr. 21-26, 30-31, 34-36, 39-40) Applicant also used hallucinogenic mushrooms in 2019. (SOR ¶ 1.d) He used hallucinogenic mushrooms twice in the span of one week in 2019 and has not used them since then. He also used lysergic acid diethylamide (LSD) in May 2019. (SOR ¶ 1.f) He used LSD twice and he has not since used it. He used both hallucinogenic mushrooms and LSD for social and experimental purposes, either at home or while camping. He obtained them from associates. He stated in his SCA, “[T]he effects were intense enough to dissuade me from having any interest in doing it again.” (GE 1) He does not intend on any future use of either substance. (GE 1-2; Tr. 26-31, 39-40) Applicant’s use and purchase of marijuana from January 2018 to August 2020, and his use of hallucinogenic mushrooms and LSD in 2019, occurred while he held a sensitive position, i.e., one in which he held a security clearance, while working for Company A. (SOR ¶¶ 1.c, 1.e, 1.g; GE 1-2; Tr. 24, 27-29, 41) He acknowledged at the hearing that he understood, since completing his December 2024 SCA, that the use of illegal drugs was incompatible with having a security clearance and eligibility for access to classified information. He also understood, during the period in which he used marijuana, hallucinogenic mushrooms, and LSD, that the use of these drugs was illegal under federal law. (Tr. 21-22, 27-29, 37) When asked why he chose to use illegal drugs while holding a sensitive position, he stated: [I]t was a -- a rather flippant attitude that I had at the time. I treated it, for lack of a better way to put it, more so as my business. I felt that it did not impede or impact my ability to do my job functions, and therefore, at the time, I’d made the – I’d made the choice that it – it wasn’t a necessarily a problem. And speaking back on shifts of perspective, you know, at the time I was younger, had a -- a whole lot less to lose. It was more of, I’m going to do as I please, was more my – my attitude at the time. And now, being in the position I’m in, I am -- now I’m more committed to doing the right thing. (Tr. 37-38) Applicant stated in his 2024 SCA, “After years of [marijuana] usage, I decided to quit. I felt that this was not a positive contributor to [my] mental health and would prefer not to do it again in the future.” (GE 1) He reiterated in his response to i
Policies
nterrogatories that he had not used illegal drugs (marijuana) since April 2024, because “[t]hey no longer appealed to me and I found myself happier without.” (GE 2) He stated in his Answer, “I 3
have abstained from all drug usage a minimum of 21 months (last usage dated April 2024). Nearly two years and a number I’m proud to continue increasing).” (Answer) He testified: Similarly to my -- to my previous statement, my priorities had shifted over the course of approximately half a decade. You know, the -- and I -- I would like to mention this again later, but a large part of it was in thanks to my wife. She has been an ex
cellent support system for me and supporting and giving me positive affirmations for the choices that I’d like to make. The life in [State 2] wasn’t what I -- I thought I had envisioned back in 2020 when I moved. And a good, a -- a dear friend of mine that works at [Company A] and has worked at [Company A] for years now, I was talking to him and, you know, we -- we exchanged notes about how our lives are going. And we kept coming back to the c onclusion that the life that I had back while I was living in [State 1] and working with [Company A] was a good life, and it -- it had became highly important for me to pursue a life that I could provide for my wife and c omfort and relative stability. That ultimately led to me deciding to abandon my usage and to return to [State 1]. (Tr. 26) Applicant indicated during his background interview that his spouse is aware of his marijuana use and purchase, and his use of hallucinogenic mushrooms and LSD. He stated his spouse has never used drugs with him, and “[s]he is a firm abstinent towards any and all drug usage.” (Tr. 34) He described her as his “N[umber] one reason for making some of the choices I’ve -- I've made in the past two or three years in that I’m trying to pursue a life of stability and constant growth.” (Tr. 31) He maintained during his background interview, in his response to interrogatories, in his Answer, and at the hearing that he does not associate with anyone involved in illegal drug use or frequent places where illegal drugs are being used. (Answer; GE 2; Tr. 26, 29-31, 34-37, 42) Applicant provided the results of a voluntary hair follicle drug test administered in April 2026, reflecting he tested negative for five illegal substances, to include marijuana. (AE B; Tr. 31-32) He stated he was drug tested by Company A when he was hired as an intern in 2015 and during pre-employment drug screening upon his return to Company A in 2024, and he has never tested positive for illegal drugs. He assumed Company A has a random drug testing policy, but he has not since been subjected to another drug test. (Tr. 29, 38-40) He stated the following in his Answer, “I hereby state my intent to abstain from all drug involvement and substance misuse and acknowledge that future involvement is grounds for revocation of national security eligibility.” (Answer) In April 2026, he provided a signed statement of intent stating, “I hereby state my intent to abstain from all illegal use of controlled substances, including the misuse of prescription and non- prescription drugs. I acknowledge that any future involvement is grounds for revocation of national
Analysis
security eligibility.” (AE A; Tr. 32-33) 4
Policies When evaluating an applicant’s suitability for a security clearance, the administrative judge must consider the adjudicative guidelines. In addition to brief introductory explanations for each guideline, the adjudicative guidelines list potentially disqualifying conditions and mitigating conditions, which are to be used in evaluating an applicant’s eligibility for access to classified information. These guidelines are not inflexible rules of law. Instead, recognizing the complexities of human behavior, administrative judges apply the guidelines in conjunction with the factors listed in the adjudicative process. The administrative judge’s overarching adjudicative goal is a fair, impartial, and commonsense decision. According to AG ¶ 2(a), the entire process is a conscientious scrutiny of a number of variables known as the “whole-person concept.” The administrative judge must consider all available, reliable information about the person, past and present, favorable and unfavorable, in making a decision. The protection of the national security is the paramount consideration. AG ¶ 2(b) requires that “[a]ny doubt concerning personnel being considered for national security eligibility will be resolved in favor of the national security.” Under Directive ¶ E3.1.14, the Government must present evidence to establish controverted facts alleged in the SOR. Under Directive ¶ E3.1.15, the applicant is responsible for presenting “witnesses and other evidence to rebut, explain, extenuate, or mitigate facts admitted by the applicant or proven by Department Counsel.” The applicant has the ultimate burden of persuasion to obtain a favorable security decision. A person who seeks access to classified information enters into a fiduciary relationship with the Government predicated upon trust and confidence. This relationship transcends normal duty hours and endures throughout off-duty hours. The Government reposes a high degree of trust and confidence in individuals to whom it grants access to classified information. Decisions include, by necessity, consideration of the possible risk the applicant may deliberately or inadvertently fail to safeguard classified information. Such decisions entail a certain degree of legally permissible extrapolation of potential, rather than actual, risk of “compromise of classified information. Section 7 of Exec. Or. 10865 provides that adverse decisions shall be “in terms of the national interest and shall in no sense be a determination as to the loyalty of the applicant concerned.” See also Exec. Or. 12968, Section 3.1(b) (listing multiple prerequisites for access to classified or sensitive information). Analysis Guideline H: Drug Involvement and Substance Misuse The security concern for drug involvement and substance misuse is set out in AG ¶ 24: 5
The illegal use of controlled substances, to include the misuse of prescription and non-prescription drugs, and the use of other substances that cause physical or mental impairment or are used in a manner inconsistent with their intended purpose can raise questions about an individual’s reliability and trustworthiness, both because such behavior may lead to physical or psychological impairment and because it raises questions about a person’s ability or willingness to comply with laws, rules, and regulations. Controlled substance means any “controlled substance” as defined in 21 U.S.C. 802. Substance misuse is the generic term adopted in this guideline to describe any of the behaviors listed above. The guideline notes the following applicable conditions that could raise security concerns under AG ¶ 25: (a) any substance misuse . . . ; (c) illegal possession of a controlled substance, including cultivation, processing, manufacture, purchase, sale, or distribution; or possession of drug paraphernalia; and (f) any illegal drug use while granted access to classified information or holding a sensitive position. Applicant used and purchased marijuana from January 2018 to April 2024. He also used hallucinogenic mushrooms and LSD in 2019. His use and purchase of marijuana from 2018 to 2020, and his use of hallucinogenic mushrooms and LSD in 2019, occurred while holding a sensitive position within Company A and having access to classified information. AG ¶¶ 25(a), 25(c), and 25(f) apply. AG ¶ 26 provides the following potentially relevant mitigating conditions: (a) the behavior happened so long ago, was so infrequent, or happened under such circumstances that it is unlikely to recur or does not cast doubt on the individual’s current reliability, trustworthiness, or good judgment; and (b) the individual acknowledges his or her drug involvement and substance misuse, provides evidence of actions taken to overcome this problem, and has established a pattern of abstinence, including, but not limited to: . . . (1) disassociation from drug-using associates and contacts; (2) changing or avoiding the environment where drugs were used; and (3) providing a signed statement of intent to abstain from all drug involvement and substance misuse, acknowledging that any future 6
involvement or misuse is grounds for revocation of national security eligibility. Marijuana is currently listed on Schedule I of the Controlled Substances Act. See 21 U.S.C. § 812(c); Drug Enforcement Administration (DEA) listing at https://www.dea.gov/drug-information/drug-scheduling (information link on bottom of web page). His multiple possessions of marijuana are federal crimes. Drugs listed as Schedule I Controlled Substances, have “no ‘currently accepted medical use in treatment.’ 21 U.S.C. § 812(a)(1)(B).” ISCR Case No. 24-01307 at 3 (App. Bd. July 17, 2025). See DEA website, supra; Executive Order, Increasing Medical Marijuana and Cannabidiol Research (December 18, 2025). The scheduling of marijuana is under DEA review, and it may be downgraded from Schedule I to Schedule III, which would permit marijuana possession and use based on prescriptions. Id. In addition, in October 2014, noting the recent decriminalization of marijuana use in several states and the District of Columbia, the Director of National Intelligence (DNI) issued a memorandum titled, “Adherence to Federal Laws Prohibiting Marijuana Use.” It reminded agency heads that such changes to state marijuana laws do not alter the existing National Security Adjudicative Guidelines and asserting that an individual’s disregard of federal marijuana law remains adjudicatively relevant in national security determinations. Subsequently, on December 21, 2021, in response to the increasing number of state and local governments legalizing or decriminalizing marijuana use, the DNI Security Executive Agent issued Clarifying Guidance Concerning Marijuana for Agencies Conducting Adjudications of Persons Proposed for Eligibility for Access to Classified Information or Eligibility to Hold a Sensitive Position (Clarifying Guidance). It instructs that “prior recreational marijuana use by an individual may be relevant to adjudications but not determinative,” and reiterates the requirement that agencies utilize the Whole-Person Concept “to carefully weigh a number of variables in an individual’s life to determine whether that individual’s behavior raises a security concern, if at all
Whole Person Concept
. 24-01307 at 3 (App. Bd. July 17, 2025). See DEA website, supra; Executive Order, Increasing Medical Marijuana and Cannabidiol Research (December 18, 2025). The scheduling of marijuana is under DEA review, and it may be downgraded from Schedule I to Schedule III, which would permit marijuana possession and use based on prescriptions. Id. In addition, in October 2014, noting the recent decriminalization of marijuana use in several states and the District of Columbia, the Director of National Intelligence (DNI) issued a memorandum titled, “Adherence to Federal Laws Prohibiting Marijuana Use.” It reminded agency heads that such changes to state marijuana laws do not alter the existing National Security Adjudicative Guidelines and asserting that an individual’s disregard of federal marijuana law remains adjudicatively relevant in national security determinations. Subsequently, on December 21, 2021, in response to the increasing number of state and local governments legalizing or decriminalizing marijuana use, the DNI Security Executive Agent issued Clarifying Guidance Concerning Marijuana for Agencies Conducting Adjudications of Persons Proposed for Eligibility for Access to Classified Information or Eligibility to Hold a Sensitive Position (Clarifying Guidance). It instructs that “prior recreational marijuana use by an individual may be relevant to adjudications but not determinative,” and reiterates the requirement that agencies utilize the Whole-Person Concept “to carefully weigh a number of variables in an individual’s life to determine whether that individual’s behavior raises a security concern, if at all
Formal Findings
, and whether that concern has been mitigated such that the individual may now receive a favorable adjudicative determination.” Applicants cannot be expected to be constitutional law experts or versed in the concept of Federal supremacy. The conflict between state and federal drug laws and the ensuing confusion was addressed by the Clarifying Guidance. Relevant to the topic of notice, the Clarifying Guidance encourages employers “to advise prospective national security workforce employees that they should refrain from any future marijuana use upon initiation of the national security vetting process, which commences once the individual signs the certification contained in the [SCA].” Implicit in this guidance is the recognition that the SCA itself no longer puts applicants on notice that marijuana use is prohibited under federal law and that employers should affirmatively be providing notice to prospective employees. The Clarifying Guidance to employers, however, cannot be presumed to have been followed. See ISCR Case No. 23-00476 (App. Bd. May 1, 2024). 7
Conclusion
Applicant was candid about his prior, experimental use of hallucinogenic mushrooms and LSD in 2019, seven years ago when he was in his 20’s. He did